PTEN and neoplasm: Preclinical research has shown that the essential lipid kinase that predominantly regulates PI3K pathway activation, cell proliferation, and survival in PTEN-deficient tumor cells is the PI3Kβ isoform (containing the p110β catalytic subunit).